Before becoming a startup in Senegal courted by the Google accelerator – raising several million euros and winning over major clients such as Nestlé and Lactalis – Lengo.ai was a project nurtured by a ...

Lengo is not a sound-masking solution. But perhaps it's a second cousin to sound-masking. One of the quirkier offerings I saw at Infocomm 2017 was Lengo by Lencore. A good writer would have included a ...

SAN DIEGO--(BUSINESS WIRE)--Lengo Therapeutics, a biopharmaceutical company developing novel precision medicines targeting driver mutations in oncology, today announced the appointment of Enoch K.

MENLO PARK, Calif. & BANGALORE, India--(BUSINESS WIRE)--Frazier Healthcare Partners (“Frazier”) today announced the launch of Lengo Therapeutics, Inc. (“Lengo”), a biopharmaceutical company focused on ...

(RTTNews) - Blueprint Medicines Corporation (BPMC), said on Monday that it inked a definitive agreement to acquire Lengo Therapeutics, a privately held precision oncology firm, for $250 million in ...

San Diego oncology startup Lengo Therapeutics is being acquired by publicly traded Blueprint Medicines for $250 million in cash — and possibly more if it hits certain milestones — to push forward an ...

SAN DIEGO--(BUSINESS WIRE)--Lengo Therapeutics, a biopharmaceutical company developing novel precision medicines targeting driver mutations in oncology, today announced the appointment of Diana ...

Company appoints Dr. Paul Pearson as Chief of Development, Dr. Eric Gruff as Senior Vice President (SVP) of CMC and Ingrid Simms as SVP and Principal Accounting Officer Their decades of experience ...

Targeted cancer drug specialist Blueprint Medicines has agreed to pay $250 million upfront to acquire Lengo Therapeutics and its lead drug for lung cancer, a rival to already-approved therapies from ...

Targeted cancer drug specialist Blueprint Medicines has agreed to pay $250 million upfront to acquire Lengo Therapeutics and its lead drug for lung cancer, a rival to already-approved therapies from ...